+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Minimal Invasive Spinal Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 377 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6106064
The global market for Minimal Invasive Spinal Devices was estimated at US$1.0 Billion in 2024 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Minimal Invasive Spinal Devices market.

Global Minimally Invasive Spinal Devices Market - Key Trends & Drivers Summarized

How Are Minimally Invasive Spinal Devices Revolutionizing Spinal Surgery and Patient Recovery?

Minimally invasive spinal devices are dramatically reshaping the field of spinal surgery by offering solutions that reduce tissue trauma, decrease recovery times, and improve overall surgical outcomes. Traditional open spine procedures often require large incisions, extended hospital stays, and prolonged rehabilitation due to the extensive muscle and tissue disruption involved. In contrast, minimally invasive techniques utilize specialized devices and instruments to access the spine through small incisions, guided by real-time imaging such as fluoroscopy or intraoperative navigation systems. These procedures result in less blood loss, reduced postoperative pain, and quicker mobilization for patients. Devices such as tubular retractors, endoscopic tools, and percutaneous pedicle screws allow surgeons to treat spinal conditions like herniated discs, spinal stenosis, and degenerative disc disease with high precision while preserving surrounding structures. Innovations in imaging and instrumentation have also enabled more complex procedures, including spinal fusion and deformity correction, to be performed using minimally invasive approaches. This shift not only benefits patient recovery but also improves operating room efficiency and lowers the risk of complications such as infections or adjacent segment degeneration. Surgeons are increasingly adopting these devices to treat a broader range of spinal pathologies, motivated by both clinical results and growing patient demand for faster, less invasive procedures. As a result, minimally invasive spinal devices are setting new standards in surgical care, helping hospitals reduce costs while delivering superior patient outcomes.

Why Is the Demand for Minimally Invasive Spinal Devices Surging Among Aging Populations and Active Lifestyles?

The demand for minimally invasive spinal devices is surging globally, driven largely by demographic trends and shifting patient expectations. One of the most significant contributors to market growth is the increasing prevalence of spinal disorders in aging populations. As life expectancy rises worldwide, so too does the incidence of age-related conditions such as spinal stenosis, spondylolisthesis, and osteoporotic fractures. Minimally invasive procedures are particularly well-suited to older patients, as they reduce the physiological burden of surgery and lower the risk of complications that are more common in elderly individuals. Additionally, today's older adults are more active than previous generations and are often unwilling to endure the extended recovery periods associated with traditional open surgeries. On the other end of the spectrum, younger patients suffering from sports injuries or work-related spinal trauma are also seeking solutions that minimize downtime and allow for a rapid return to daily activities. This convergence of needs across different age groups is creating strong momentum for the adoption of advanced, minimally invasive devices. Furthermore, improvements in healthcare infrastructure and insurance coverage in emerging economies are making these treatments more accessible to broader patient populations. The combination of demographic shifts, increased awareness, and greater surgical availability is propelling the minimally invasive spinal device market to the forefront of modern orthopedic and neurological care.

How Are Technological Advancements Expanding the Capabilities of Minimally Invasive Spinal Devices?

Technological advancements are expanding the capabilities of minimally invasive spinal devices, enabling more precise, versatile, and patient-specific treatments than ever before. Innovations in robotic-assisted surgery, navigation systems, and real-time imaging are helping surgeons perform complex procedures with greater accuracy and minimal disruption to healthy tissues. Robotic platforms provide enhanced control and consistency during instrumentation placement, reducing variability and improving surgical outcomes. Intraoperative navigation systems, which use 3D imaging and augmented reality overlays, allow for detailed anatomical visualization, helping surgeons avoid critical structures while optimizing implant positioning. At the same time, the design of spinal implants has evolved significantly, with newer materials such as titanium alloys and polyetheretherketone (PEEK) offering improved biocompatibility, strength, and radiolucency. Expandable interbody cages and modular fixation systems are facilitating customized spinal alignment and load sharing, tailored to the unique needs of each patient. Additionally, device miniaturization and enhanced ergonomics are allowing for smaller incisions and quicker instrument exchanges during surgery. Some devices now feature integrated biologics delivery systems, enabling simultaneous placement of bone graft materials for improved fusion rates. The integration of data analytics and AI into surgical planning is further personalizing the selection and use of devices, optimizing outcomes for different patient profiles. As these technologies become more refined and widely adopted, they are redefining the standard of care in spinal surgery, pushing the boundaries of what can be achieved through minimally invasive approaches.

What Are the Key Drivers Behind the Global Growth of the Minimally Invasive Spinal Devices Market?

The growth in the minimally invasive spinal devices market is driven by a combination of clinical, technological, demographic, and economic factors that are reshaping spinal care globally. One of the foremost drivers is the proven clinical benefits of minimally invasive surgery, which include reduced postoperative pain, shorter hospital stays, faster recovery, and lower rates of complications. These outcomes translate into higher patient satisfaction and lower overall treatment costs, making the approach attractive to both providers and payers. Increasing awareness of these benefits among patients is also prompting more individuals to seek minimally invasive solutions, especially as information about surgical options becomes more widely accessible online and through healthcare networks. From a provider perspective, hospitals and surgical centers are prioritizing these procedures to meet demand, boost throughput, and remain competitive in the growing field of outpatient spine surgery. Technological advancements have made it possible to treat a broader range of spinal pathologies using minimally invasive methods, expanding the addressable market and encouraging wider adoption. Furthermore, the expansion of ambulatory surgical centers and improvements in reimbursement policies are creating new opportunities for minimally invasive spinal device manufacturers. Aging populations in developed nations and improving access to specialized care in emerging markets are further contributing to market expansion. Together, these factors are establishing minimally invasive spinal devices as a core component of future-ready spinal care systems, supported by innovation, clinical evidence, and growing global demand for less invasive treatment alternatives.

Scope Of Study:

The report analyzes the Minimal Invasive Spinal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Device Type (Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device, Other Device Types); Application (Spine Fusion Procedure Application, Spine Non-Fusion Procedure Application); End-Use (Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use, Academic & Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Endoscope Device segment, which is expected to reach US$582.0 Million by 2030 with a CAGR of a 6.3%. The Fluoroscope Device segment is also set to grow at 3.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $278.6 Million in 2024, and China, forecasted to grow at an impressive 8.2% CAGR to reach $276.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Minimal Invasive Spinal Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Minimal Invasive Spinal Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Minimal Invasive Spinal Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Aesculap Inc. (B. Braun), Alphatec Spine, Inc., Amendia, Inc., Aurora Spine Corporation, Bioventus Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 41 companies featured in this Minimal Invasive Spinal Devices market report include:

  • Aesculap Inc. (B. Braun)
  • Alphatec Spine, Inc.
  • Amendia, Inc.
  • Aurora Spine Corporation
  • Bioventus Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • Joimax GmbH
  • Life Spine, Inc.
  • Medacta Group SA
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • RTI Surgical
  • SeaSpine Holdings Corporation
  • Spineart SA
  • Spinal Elements, Inc.
  • Stryker Corporation
  • Ulrich Medical
  • Zimmer Biomet Holdings, Inc.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Minimal Invasive Spinal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Degenerative Spinal Disorders Throws the Spotlight on Minimally Invasive Solutions
  • Surge in Geriatric Population Drives Demand for Low-Trauma Spinal Devices with Faster Recovery Profiles
  • Technological Advancements in Navigation and Imaging Systems Propel Adoption of Precision-Guided Implants
  • Shift Toward Outpatient and Ambulatory Surgical Settings Strengthens the Business Case for Minimally Invasive Devices
  • Growing Preference for Motion Preservation Techniques Spurs Innovation in Dynamic Stabilization Implants
  • Reduced Hospital Stay and Postoperative Complications Fuels Growth of MIS Spinal Technologies
  • Expanding Use of Robotics and AI in Spine Surgery Accelerates Demand for Compatible Minimally Invasive Systems
  • Increasing Acceptance of Minimally Invasive Fusion Techniques Generates Demand for Advanced Interbody Devices
  • Surge in Sports Injuries and Trauma Cases Among Young Adults Drives Adoption of MIS Interventions
  • Integration of Augmented Reality in Surgical Workflows Enhances Accuracy and Broadens Adoption of MIS Devices
  • Rising Patient Awareness and Demand for Cosmetic and Functional Outcomes Spur Market Penetration
  • Growth in Spinal Endoscopy and Percutaneous Approaches Expands the Addressable Market for Specialized Devices
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Minimal Invasive Spinal Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Minimal Invasive Spinal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Minimal Invasive Spinal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Endoscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Endoscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Endoscope Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Fluoroscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Fluoroscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Fluoroscope Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Minimally Invasive Tubular Retractor Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Minimally Invasive Tubular Retractor Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Minimally Invasive Tubular Retractor Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Spine Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Spine Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Spine Fusion Procedure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Spine Non-Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Spine Non-Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Spine Non-Fusion Procedure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aesculap Inc. (B. Braun)
  • Alphatec Spine, Inc.
  • Amendia, Inc.
  • Aurora Spine Corporation
  • Bioventus Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • Joimax GmbH
  • Life Spine, Inc.
  • Medacta Group SA
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • RTI Surgical
  • SeaSpine Holdings Corporation
  • Spineart SA
  • Spinal Elements, Inc.
  • Stryker Corporation
  • Ulrich Medical
  • Zimmer Biomet Holdings, Inc.

Table Information